title: Relationship between number of allergic sensitizations and immunity impairment: anything new in immunotherapy for allergies and vaccines planning?
abstract: To 106 14-56 year-old allergic people (30 monosensitized, 24 sensitized to 2 pollens, 52 polysensitized) we have evaluated the Global Immune Competence Status (GICS). That's a compound score, made of ten parameters, six regarding cell-mediated immunity (WBC/mmc, Gr/mmc, Ly/mmc, Ly CD3+/mmc, Ly CD4+/mmc, CD4/CD8 Ratio), four regarding nutritional status and humoral immunity (Tot. Protein mg/dl, Albumin mg/dl, Gammaglobulins mg/dl, IgG mg/dl). Each parameter is brought on a grid including 4 worth scores worsening from 4 to 1, related to different ranges of values; this way quickly leads to characterize type and grade of immune deficiency. So doing we found that in 30 monosensitized people 27 (90%) show a complete immune competence, while just 3 people (10%) have impaired GICS: in these 1 (3%) regards cell-mediated immunity, while 2 (7%) regard humoral immunity. In 24 patients sensitized to 2 allergenes, 18 (75%) showed complete immune competence, while 6 (25%) a GICS impairment regarding cell-mediated immunity. In leaving 52 polysensitized patients, 30 people showed complete immune competence (58%), while 20 (38%) showed a GICS impairment regarding cell-mediated immunity and 2 (4%) impaired humoral immunity. This work shows that the higher the number of sensitizations is, the stronger the cell-mediated immunity impairment in allergic people become.
authors.affiliation: Allergy and Clinical Immunology Unit, Dept. of General and Specialistic Medicine Religious General Regional Hospital F. Miulli, Acquaviva delle Fonti (BA), Italy. giacomo_manfredi@fastwebnet.it
authors.forename: G
authors.initials: G
authors.lastname: Manfredi
authors.forename: G
authors.initials: G
authors.lastname: Lucarelli
authors.forename: C
authors.initials: C
authors.lastname: Derosa
authors.forename: E
authors.initials: E
authors.lastname: Ventura
mesh_terms: D000293:Adolescent; D000328:Adult; D000917:Antibody Formation / Q000276:immunology; D003888:Desensitization, Immunologic / Q000009:adverse effects*; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control*; D007154:Immune System Diseases / Q000209:etiology*; D007111:Immunity, Cellular / Q000276:immunology*; D008875:Middle Aged; D014612:Vaccines / Q000009:adverse effects*
chemical_list: D014612:Vaccines